Hadfield Stephen J, Pachebat Justin A, Swain Martin T, Robinson Guy, Cameron Simon Js, Alexander Jenna, Hegarty Matthew J, Elwin Kristin, Chalmers Rachel M
Cryptosporidium Reference Unit, Public Health Wales Microbiology ABM, Singleton Hospital, Sgeti, Swansea, SA2 8QA, United Kingdom.
Institute of Biological, Environmental & Rural Sciences, Aberystwyth University, Penglais, Aberystwyth, Ceredigion, SY23 3DA, United Kingdom.
BMC Genomics. 2015 Aug 29;16(1):650. doi: 10.1186/s12864-015-1805-9.
Whole genome sequencing (WGS) of Cryptosporidium spp. has previously relied on propagation of the parasite in animals to generate enough oocysts from which to extract DNA of sufficient quantity and purity for analysis. We have developed and validated a method for preparation of genomic Cryptosporidium DNA suitable for WGS directly from human stool samples and used it to generate 10 high-quality whole Cryptosporidium genome assemblies. Our method uses a combination of salt flotation, immunomagnetic separation (IMS), and surface sterilisation of oocysts prior to DNA extraction, with subsequent use of the transposome-based Nextera XT kit to generate libraries for sequencing on Illumina platforms. IMS was found to be superior to caesium chloride density centrifugation for purification of oocysts from small volume stool samples and for reducing levels of contaminant DNA.
The IMS-based method was used initially to sequence whole genomes of Cryptosporidium hominis gp60 subtype IbA10G2 and Cryptosporidium parvum gp60 subtype IIaA19G1R2 from small amounts of stool left over from diagnostic testing of clinical cases of cryptosporidiosis. The C. parvum isolate was sequenced to a mean depth of 51.8X with reads covering 100 % of the bases of the C. parvum Iowa II reference genome (Bioproject PRJNA 15586), while the C. hominis isolate was sequenced to a mean depth of 34.7X with reads covering 98 % of the bases of the C. hominis TU502 v1 reference genome (Bioproject PRJNA 15585). The method was then applied to a further 17 stools, successfully generating another eight new whole genome sequences, of which two were C. hominis (gp60 subtypes IbA10G2 and IaA14R3) and six C. parvum (gp60 subtypes IIaA15G2R1 from three samples, and one each of IIaA17G1R1, IIaA18G2R1, and IIdA22G1), demonstrating the utility of this method to sequence Cryptosporidium genomes directly from clinical samples. This development is especially important as it reduces the requirement to propagate Cryptosporidium oocysts in animal models prior to genome sequencing.
This represents the first report of high-quality whole genome sequencing of Cryptosporidium isolates prepared directly from human stool samples.
隐孢子虫属的全基因组测序(WGS)此前依赖于在动物体内繁殖寄生虫,以产生足够数量的卵囊,从中提取足够量和纯度的DNA用于分析。我们已经开发并验证了一种直接从人类粪便样本中制备适合WGS的隐孢子虫基因组DNA的方法,并使用该方法生成了10个高质量的隐孢子虫全基因组组装。我们的方法在DNA提取前,结合了盐浮选、免疫磁珠分离(IMS)和卵囊表面消毒,随后使用基于转座体的Nextera XT试剂盒生成文库,以便在Illumina平台上进行测序。研究发现,在从小体积粪便样本中纯化卵囊以及降低污染DNA水平方面,IMS优于氯化铯密度离心法。
基于IMS的方法最初用于对隐孢子虫病临床病例诊断检测剩余的少量粪便中的人隐孢子虫gp60亚型IbA10G2和微小隐孢子虫gp60亚型IIaA19G1R2的全基因组进行测序。微小隐孢子虫分离株的测序平均深度为51.8X,读数覆盖了微小隐孢子虫爱荷华II参考基因组(生物项目PRJNA 15586)100%的碱基,而人隐孢子虫分离株的测序平均深度为34.7X,读数覆盖了人隐孢子虫TU502 v1参考基因组(生物项目PRJNA 15585)98%的碱基。然后将该方法应用于另外17份粪便样本,成功生成了另外8个新的全基因组序列,其中2个是人隐孢子虫(gp60亚型IbA10G2和IaA14R3),6个是微小隐孢子虫(3个样本的gp60亚型IIaA15G2R1,以及IIaA17G1R1、IIaA18G2R1和IIdA22G1各1个),证明了该方法直接从临床样本中对隐孢子虫基因组进行测序的实用性。这一进展尤为重要,因为它减少了在基因组测序前在动物模型中繁殖隐孢子虫卵囊的需求。
这是关于直接从人类粪便样本中制备的隐孢子虫分离株进行高质量全基因组测序的首次报告。